SCARB1 and cancer: To conclude, our data strongly suggest that in normal cells, the pathway leading to CE increase is related to the passage from quiescence to proliferation and is achieved mainly through CE-HDL/SR-BI/LDs pathway, which remains continuously active in cancer cells.